» Articles » PMID: 6794445

Susceptibility of Enterococci and Listeria Monocytogenes to N-Formimidoyl Thienamycin Alone and in Combination with an Aminoglycoside

Overview
Specialty Pharmacology
Date 1981 May 1
PMID 6794445
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The susceptibilities of 12 strains of enterococci and 10 stains of Listeria monocytogenes to N-formimidoyl thienamycin were determined by a standard broth dilution method. Minimal inhibitory concentrations for L. monocytogenes strains were less than 0.25 micrograms/ml. As a group, strains of Streptococcus faecium were less susceptible than Streptococcus faecalis strains, but even for the latter, the minimal inhibitory concentrations were slightly greater than those previously reported. Minimal bactericidal concentrations against all organisms were many-fold higher than the corresponding inhibitory concentrations. In time-kill studies, combinations of N-formimidoyl thienamycin with gentamicin were synergistic against (or they completely sterilized cultures of) all the enterococcal strains and nine to 10 strains of L. monocytogenes. The magnitude of killing by the combinations was comparable to that previously observed with penicillin-gentamicin combinations. N-Formimidoyl thienamycin-tobramycin combinations were synergistic against those strains of S. faecalis and L. monocytogenes tested, but not against those of S. faecium.

Citing Articles

Antimicrobial Resistance of from Animal Foods to First- and Second-Line Drugs in the Treatment of Listeriosis from 2008 to 2021: A Systematic Review and Meta-Analysis.

Reis J, Vieira B, Cunha Neto A, Castro V, Figueiredo E Can J Infect Dis Med Microbiol. 2022; 2022:1351983.

PMID: 36249588 PMC: 9568363. DOI: 10.1155/2022/1351983.


Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem.

Weinstein M, Mirrett S, Kannangara S, Monahan J, Harrell L, Wilson A J Clin Microbiol. 2004; 42(8):3747-51.

PMID: 15297525 PMC: 497596. DOI: 10.1128/JCM.42.8.3747-3751.2004.


Prediction of enterococcal imipenem susceptibility using ampicillin or penicillin MICs: more evidence for a class concept.

Jones R J Clin Microbiol. 2001; 39(10):3810-1.

PMID: 11599520 PMC: 88444. DOI: 10.1128/JCM.39.10.3810-3811.2001.


Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

Weinstein M J Clin Microbiol. 2001; 39(7):2729-31.

PMID: 11427608 PMC: 88224. DOI: 10.1128/JCM.39.7.2729-2731.2001.


Management of listeriosis.

Hof H, Nichterlein T, Kretschmar M Clin Microbiol Rev. 1997; 10(2):345-57.

PMID: 9105758 PMC: 172923. DOI: 10.1128/CMR.10.2.345.


References
1.
Moellering Jr R, Medoff G, Leech I, WENNERSTEN C, KUNZ L . Antibiotic synergism against Listeria monocytogenes. Antimicrob Agents Chemother. 1972; 1(1):30-4. PMC: 444161. DOI: 10.1128/AAC.1.1.30. View

2.
KROPP H, Sundelof J, Kahan J, KAHAN F, Birnbaum J . MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities. Antimicrob Agents Chemother. 1980; 17(6):993-1000. PMC: 283917. DOI: 10.1128/AAC.17.6.993. View

3.
Mohan K, Gordon R, Beaman T, BELDING R, Luecke D, Edmiston C . Synergism of penicillin and gentamicin against Listeria monocytogenes in ex vivo hemodialysis culture. J Infect Dis. 1977; 135(1):51-4. DOI: 10.1093/infdis/135.1.51. View

4.
WIGGINS G, Albritton W, Feeley J . Antibiotic susceptibility of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother. 1978; 13(5):854-60. PMC: 352344. DOI: 10.1128/AAC.13.5.854. View

5.
Saravolatz L, Burch K, Madhavan T, QUINN E . Listerial prosthetic valve endocarditis. Successful medical therapy. JAMA. 1978; 240(20):2186-7. View